首页 | 本学科首页   官方微博 | 高级检索  
检索        

芍药汤对溃疡性结肠炎大鼠肠黏膜免疫屏障的干预作用
引用本文:吴东升,曹晖,张彧,高亚,宾东华.芍药汤对溃疡性结肠炎大鼠肠黏膜免疫屏障的干预作用[J].中国实验方剂学杂志,2019,25(9):6-11.
作者姓名:吴东升  曹晖  张彧  高亚  宾东华
作者单位:湖南中医药大学, 长沙 410208,湖南中医药大学 第一附属医院, 长沙 410007,湖南中医药大学, 长沙 410208,湖南中医药大学 第一附属医院, 长沙 410007,湖南中医药大学 第一附属医院, 长沙 410007
基金项目:国家自然科学基金项目(81603634);2018年度湖南省中医药科研计划项目(201804);湖南省卫生计生委2018年度科研计划课题项目(C20180627);湖南中医药大学校级科研基金项目(ZYYDX201733)
摘    要:目的:探讨芍药汤对2,4,6-三硝基苯磺酸(TNBS)诱导的溃疡性结肠炎大鼠肠黏膜免疫屏障的影响。方法:将60只SD大鼠随机分为正常组,模型组,美沙拉嗪组(0.067 g·kg~(-1)),芍药汤低、中、高剂量组(1.8,3.6,7.2 g·kg~(-1)),采用TNBS诱导溃疡性结肠炎模型,对应给予生理盐水、美沙拉嗪、芍药汤灌胃治疗7 d,采用苏木素-伊红(HE)染色观察结肠组织病理学改变,免疫组化法和蛋白免疫印迹法(Western blot)检测肠黏膜中CD4~+T淋巴细胞数量和分泌型免疫球蛋白A(SIg A)蛋白的表达。结果:与正常组比较,模型组大鼠肠黏膜损伤程度评分及病理学评分显著升高(P0.01);CD4~+T淋巴细胞,SIg A蛋白表达显著下降(P0.01);与模型组比较,各给药组大鼠结肠黏膜损伤程度评分及病理学评分显著下降(P0.01),肠黏膜CD4~+T淋巴细胞,SIg A表达明显升高(P0.05,P0.01);与美沙拉嗪组及芍药汤低剂量组比较,芍药汤中、高剂量组肠黏膜损伤程度评分和病理学评分显著下降(P0.01),芍药汤中、高剂量组大鼠肠黏膜中CD4~+T淋巴细胞及SIg A蛋白表达明显升高(P0.05)。结论:芍药汤可通过增加肠黏膜中CD4~+T细胞数量及SIg A分泌的表达,起到减轻肠黏膜损伤,保护肠黏膜免疫屏障功能作用。

关 键 词:芍药汤  2  4  6-三硝基苯磺酸  溃疡性结肠炎  肠黏膜免疫屏障  分泌型免疫球蛋白A
收稿时间:2018/11/3 0:00:00

Intervention Effect of Shaoyaotang on Intestinal Mucosal Immune Barrier in Rats with Ulcerative Colitis
WU Dong-sheng,CAO Hui,ZHANG Yu,GAO Ya and BIN Dong-hua.Intervention Effect of Shaoyaotang on Intestinal Mucosal Immune Barrier in Rats with Ulcerative Colitis[J].China Journal of Experimental Traditional Medical Formulae,2019,25(9):6-11.
Authors:WU Dong-sheng  CAO Hui  ZHANG Yu  GAO Ya and BIN Dong-hua
Institution:Hunan University of Traditional Chinese Medicine(TCM), Changsha 410208, China,The First Affiliated Hospital of Hunan University of TCM, Changsha 410007, China,Hunan University of Traditional Chinese Medicine(TCM), Changsha 410208, China,The First Affiliated Hospital of Hunan University of TCM, Changsha 410007, China and The First Affiliated Hospital of Hunan University of TCM, Changsha 410007, China
Abstract:Objective: To investigate effect of Shaoyaotang on intestinal mucosal immune barrier induced by 2,4,6-trinitrobenzene sulphonic acid (TNBS) in rats with ulcerative colitis.Method: Sixty SD rats were randomly divided into normal group,model group,mesalazine group (0.067 mg·kg-1),low,medium and high-dose Shaoyaotang groups (1.8,3.6,7.2 g·kg-1).In the TNBS-induced ulcerative colitis model,saline,mesalazine,peony soup were administered by gavage for 7 days.Hematoxylin-eosin (HE) staining was used to detect the histopathological changes of colon tissue.The number of CD4+T lymphocytes and the expression of secretory immunoglobulin A (SIgA) in intestinal mucosa were detected by immunohistochemistry and Western blot.Result: Compared with normal group,the scores of intestinal mucosal injury and the pathological scores in model group increased significantly (P<0.01).The expressions of CD4+T lymphocytes and SIgA in the intestinal mucosa of model group decreased significantly (P<0.01).Compared with model group,the scores of colonic mucosal damage and the pathological scores decreased significantly in rats (P<0.01).The expressions of CD4+T lymphocytes and SIgA in the intestinal mucosa of rats in each group elevated significantly (P<0.05,P<0.01).Compared with mesalazine group and low-dose Shaoyaotang group,the intestinal mucosal injury score and the pathological scores in medium and high-dose Shaoyaotang groups decreased significantly (P<0.01).The expression levels of CD4+T lymphocytes and SIgA protein in the intestinal mucosa of rats in middle and high doses Shaoyaotang groups increased significantly (P<0.05).Conclusion: Shaoyaotang can reduce the intestinal mucosal damage and protect the intestinal mucosal immune barrier by increasing the number of CD4+T cells and the expression of SIgA secretion in the intestinal mucosa.
Keywords:Shaoyaotang  2  4  6-trinitrobenzenesulfonic acid  ulcerative colitis  intestinal mucosal immune barrier  secretory immunoglobulin A
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号